In conjunction with IL-6, IFNγ plays a major role in modulation of the cancer immune network to inhibit or promote tumor progression (Landskron et al., 2014; Shalapour and Karin, 2015; Mojic et al., 2017). Here, IFNG is linked to neoplasm.